Asia Pacific DNA Extraction, Isolation, and Purification Market

The Asia Pacific DNA extraction, isolation, and purification market was valued at US$ 505.36 million in 2022 and is expected to reach US$ 1,014.29 million by 2030; it is estimated to grow at a CAGR of 9.1% from 2022 to 2030.

Rising R&D in Genomics Fuels the Asia Pacific DNA Extraction, Isolation, and Purification Market

Genomics holds significant potential for improved diagnostics and treatment of genetic diseases. Genomic DNA extraction is one of the most common procedures in the life sciences. Genomic DNA contains all of an organism's genetic and chromosomal material and encodes all of the components required for life. The emergence of cutting-edge technologies for sequencing, and assembly and analysis of sequenced data is likely to strengthen the importance of genomics in medicine and other branches of science. Thus, government and nongovernment agencies are taking initiatives to boost genomic research. The funding enables researchers to provide world-class genomic healthcare, which involves the study of people's DNA as a core job.

Asia Pacific DNA Extraction, Isolation, and Purification Market Overview

The Asia Pacific DNA extraction, isolation, and purification market is expected to record a highest CAGR during 2022-2030. Gastric cancer is the third leading cause of cancer-related deaths in China. The country accounts for more than 40% of new gastric cancer cases out of 1.09 million new cases reported globally; the disease caused ~12% of cancer-related deaths in China in 2020. According to the WCRF International, China had a significant incidence age-standardized rate of 203.8 cancer cases per 100,000, with 4,546,400 new cases in 2020. Japan has a fast-aging demographic profile. According to the Organization for Economic Co-Operation and Development (OECD), people aged 60 and above are expected to account for ~40% of the total population in Japan by 2060. Therefore, the Japanese healthcare system experiences an enormous demand for advanced medical technologies and diagnostics. Further, the country has a high cancer prevalence. According to the WCRF International, Japan had a significant incidence age-standardized rate of 282.9 cancer cases per 100,000 in 2020, with 1,017,282 new cancer cases reported that year. Recently, many big pharmaceutical and nonpharmaceutical companies have invested much time and money for genomics research in India. According to a study titled "Native Americans at Higher Risk for Rare Genetic Diseases," India could be home to over 8 million people suffering from rare diseases, a collective term used to describe a spectrum of over 5,000 diseases that are usually of genetic origin. The list includes hemophilia, thalassemia, sickle cell disease, and primary immunodeficiency in children; autoimmune diseases; lysosomal storage diseases (such as Pompe disease, Hirschsprung disease, Gaucher disease, cystic fibrosis, and hemangiomas); and certain forms of muscular dystrophy. Moreover, according to a study published in 2023 in the European Journal of Human Genetics, 1,890 patients suffering from rare diseases were enrolled in the Korean Genetic Diagnosis Program for Rare Diseases (KGDP) between 2017 and 2022. This study reported that rare diseases are common in children and adolescents. Therefore, the rising cases of genetic disorders and infectious diseases favor the growth of the DNA extraction, isolation, and purification market in Asia Pacific.

Asia Pacific DNA Extraction, Isolation, and Purification Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific DNA Extraction, Isolation, and Purification Market Segmentation 

The Asia Pacific DNA extraction, isolation, and purification market is segmented based on type, method, sample type, source, application, end user, and country.

Based on type, the Asia Pacific DNA extraction, isolation, and purification market is categorized into kits, instrument, and reagent. The kits segment held the largest Asia Pacific DNA extraction, isolation, and purification market share in 2022.

In terms of method, the Asia Pacific DNA extraction, isolation, and purification market is bifurcated into chemical method and physical method. The chemical method segment held a larger Asia Pacific DNA extraction, isolation, and purification market share in 2022. The chemical method is further subsegmented into phenol chloroform, silica gel, proteinase, and others. The physical method is further subsegmented into magnetic bead and paper.

By sample type, the Asia Pacific DNA extraction, isolation, and purification market is segmented into blood, body fluid, and others. The blood segment held the largest Asia Pacific DNA extraction, isolation, and purification market share in 2022.

By source, the Asia Pacific DNA extraction, isolation, and purification market is segmented into genomic and microbial. The genomic segment held a larger Asia Pacific DNA extraction, isolation, and purification market share in 2022. The microbial segment is further subsegmented into bacteria and virus.

Based on application, the Asia Pacific DNA extraction, isolation, and purification market is categorized into PCR test, next generation sequencing, micro array, and others. The next generation sequencing segment held the largest Asia Pacific DNA extraction, isolation, and purification market share in 2022. The PCR test segment is further subsegmented into qPCR, multiplex PCR, 16S PCR, and others.

By end user, the Asia Pacific DNA extraction, isolation, and purification market is segmented into diagnostic center and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The diagnostic center and research laboratories segment held the largest Asia Pacific DNA extraction, isolation, and purification market share in 2022.

Based on country, the Asia Pacific DNA extraction, isolation, and purification market is categorized into China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and the Rest of Asia Pacific. China dominated the Asia Pacific DNA extraction, isolation, and purification market in 2022.

Agilent Technologies, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc, Illumina Inc, Merck KGaA, Qiagen NV, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific DNA extraction, isolation, and purification market.

Asia Pacific DNA Extraction, Isolation, and Purification Strategic Insights

Strategic insights for the Asia Pacific DNA Extraction, Isolation, and Purification provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific DNA Extraction, Isolation, and Purification Report Scope

Asia Pacific DNA Extraction, Isolation, and Purification Regional Insights

The geographic scope of the Asia Pacific DNA Extraction, Isolation, and Purification refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.